Literature DB >> 27085555

Dendritic cells in renal biopsies of patients with acute tubulointerstitial nephritis.

Mingyu Cheng1, Xin Gu1, Guillermo A Herrera2.   

Abstract

Dendritic cells (DCs) play a critical role in the regulation of the adaptive immune response and can be separated into 2 major subsets: myeloid (mDC) and plasmacytoid (pDC) DCs. Acute tubulointerstitial nephritis (ATIN) is a common cause of injury to renal tubules and interstitium resulting from the interplay of tubular cells and inflammatory cells and their products. However, the involvement of DCs in ATIN is still unknown. In this study, the participation and localization of myeloid (CD1c) and plasmacytoid (CD303) DC subsets in the biopsies from patients with ATIN (n=20), lupus nephritis (n=17, positive control), or minimal change disease (n=14, negative control) were investigated. DCs were identified morphologically within the tubulointerstitium in the renal biopsies by transmission electron microscopy interacting with surrounding tubules and inflammatory cells. Direct immunofluorescence showed that both CD1c+DCs and CD303+ DCs exist in all the renal biopsies. As compared with minimal change disease, biopsies with ATIN had significantly increased CD1c+DCs (P<.001) and CD303+ DCs (P<.001). The number of CD1c+DCs in ATIN was significantly higher than that in lupus nephritis (P<.02), whereas the number of CD303+ DCs in ATIN was slightly but not significantly higher than that in lupus nephritis (P=.2). DCs in the biopsies with ATIN were restricted to the tubulointerstitium forming dense networks, and most of them maintained immature state. All these findings suggest that DC subsets may be differentially involved in the pathogenesis of ATIN. Their potential role in intrarenal regulation of immune responses in ATIN is proposed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute tubulointerstial nephritis; Dendritic cells; Immune modulation; Myeloid; Plasmacytoid

Mesh:

Substances:

Year:  2016        PMID: 27085555     DOI: 10.1016/j.humpath.2016.03.020

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

Review 1.  Kidney dendritic cells: fundamental biology and functional roles in health and disease.

Authors:  Christian Kurts; Florent Ginhoux; Ulf Panzer
Journal:  Nat Rev Nephrol       Date:  2020-05-05       Impact factor: 28.314

Review 2.  The contribution of the programmed cell death machinery in innate immune cells to lupus nephritis.

Authors:  FuNien Tsai; Harris Perlman; Carla M Cuda
Journal:  Clin Immunol       Date:  2016-10-22       Impact factor: 3.969

3.  FOXP3+ T cells are present in kidney biopsy samples in children with tubulointerstitial nephritis and uveitis syndrome.

Authors:  Sari H Rytkönen; Petri Kulmala; Helena Autio-Harmainen; Pekka Arikoski; Kira Endén; Janne Kataja; Tuomo Karttunen; Matti Nuutinen; Timo Jahnukainen
Journal:  Pediatr Nephrol       Date:  2017-09-11       Impact factor: 3.714

4.  NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-α production in patients with SLE.

Authors:  Spiros Georgakis; Katerina Gkirtzimanaki; Garyfalia Papadaki; Hariklia Gakiopoulou; Elias Drakos; Maija-Leena Eloranta; Manousos Makridakis; Georgia Kontostathi; Jerome Zoidakis; Eirini Baira; Lars Rönnblom; Dimitrios T Boumpas; Prodromos Sidiropoulos; Panayotis Verginis; George Bertsias
Journal:  JCI Insight       Date:  2021-11-08

5.  Transcriptomic and Epigenetic Alterations in Dendritic Cells Correspond With Chronic Kidney Disease in Lupus Nephritis.

Authors:  Anna Wardowska; Michał Komorniczak; Barbara Bułło-Piontecka; M Alicja Dȩbska-Ślizień; Michał Pikuła
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

6.  Identification and verification of vascular cell adhesion protein 1 as an immune-related hub gene associated with the tubulointerstitial injury in diabetic kidney disease.

Authors:  Yan Jia; Hui Xu; Qi Yu; Lishan Tan; Zuying Xiong
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.